StockData
HealthEquity, Inc. logo

HealthEquity, Inc. (HQY) stock

HQYNasdaqServices-Business Services, NECFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Aug 27, 2026Score 15/307% below fair value
$102.47+1.11 (+1.10%)

Close on Oct 30, 2026Market cap $8.48BP/E 37.0Yield –

Earnings

HealthEquity's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Dec 2, 2026
Q3 FY2027 · estimated, after the close
Revenue, Q2 FY2027
$350.70M
+7.6% on a year earlier
non-GAAP net income per diluted share, Q2 FY2027
$1.24
$1.08 a year earlier
Latest guidance
Raised
Aug 27, 2026 · 6 items

Quarterly results

Revenue and earnings per share from each of HealthEquity's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q3 FY2027ended Oct 31, 2026Dec 2, 2026Expected–––––
Q2 FY2027ended Jul 31, 2026Aug 27, 2026before the open$350.70M+7.6%$0.78$1.24Release
Q1 FY2027ended Apr 30, 2026May 28, 2026after the close$354.60M+7.2%$0.82$1.24Release
Q4 FY2026ended Jan 31, 2026Feb 17, 2026after the close––––Release
Q3 FY2026ended Oct 31, 2025Dec 3, 2025after the close$322.20M+7.3%$0.59$1.01Release
Q2 FY2026ended Jul 31, 2025Sep 2, 2025after the close$325.80M+8.6%$0.68$1.08Release
Q1 FY2026ended Apr 30, 2025Jun 3, 2025after the close$330.80M+15.0%$0.61$0.97Release
Q4 FY2025ended Jan 31, 2025Mar 18, 2025after the close$311.80M+18.8%$0.30$0.69Release
Q3 FY2025ended Oct 31, 2024Dec 9, 2024after the close$300.40M+20.5%$0.06$0.78Release
Q2 FY2025ended Jul 31, 2024Sep 3, 2024after the close$299.90M+23.2%$0.40$0.86Release
Q1 FY2025ended Apr 30, 2024Jun 3, 2024after the close$287.60M+17.7%$0.33$0.80Release
Q4 FY2024ended Jan 31, 2024Mar 19, 2024after the close$262.40M+12.2%$0.30$0.63Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

HealthEquity's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
revenuesFY2027$1.41B – $1.42B$1.41B – $1.42BRaisedAug 27, 2026
Adjusted EBITDAnon-GAAPFY2027$628.00M – $636.00M$625.00M – $633.00MRaisedAug 27, 2026
net income per diluted shareGAAPFY2027$2.88 – $2.96$2.88 – $2.95RaisedAug 27, 2026
non-GAAP net income per diluted sharenon-GAAPFY2027$4.66 – $4.73$4.66 – $4.73ReaffirmedAug 27, 2026
net incomeGAAPFY2027$242.00M – $248.00M$242.00M – $248.00MReaffirmedAug 27, 2026
non-GAAP net incomenon-GAAPFY2027$392.00M – $398.00M$392.00M – $398.00MReaffirmedAug 27, 2026

Guidance vs results

The last range HealthEquity gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025EPS (GAAP)$0.99 – $1.08$1.09Σ4QAbove range
FY2025non-GAAP net income per diluted share$3.08 – $3.16$3.13Σ4QWithin range
FY2025Revenue$1.19B – $1.20B$1.20BΣ4QAbove range

Guidance history

Every forecast HealthEquity put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Aug 27, 2026Adjusted EBITDAFY2027$628.00M – $636.00MRaised
Aug 27, 2026non-GAAP net income per diluted shareFY2027$4.66 – $4.73Reaffirmed
Aug 27, 2026net income per diluted shareFY2027$2.88 – $2.96Raised
Aug 27, 2026net incomeFY2027$242.00M – $248.00MReaffirmed
Aug 27, 2026non-GAAP net incomeFY2027$392.00M – $398.00MReaffirmed
Aug 27, 2026revenuesFY2027$1.41B – $1.42BRaised
May 28, 2026Adjusted EBITDAFY2027$625.00M – $633.00MNew
May 28, 2026non-GAAP net income per diluted shareFY2027$4.66 – $4.73New
May 28, 2026net income per diluted shareFY2027$2.88 – $2.95New
May 28, 2026net incomeFY2027$242.00M – $248.00MNew
May 28, 2026non-GAAP net incomeFY2027$392.00M – $398.00MNew
May 28, 2026revenuesFY2027$1.41B – $1.42BNew
Dec 3, 2025Adjusted EBITDAFY2026$555.00M – $565.00MRaised
Dec 3, 2025non-GAAP net income per diluted shareFY2026$3.87 – $3.95Raised
Dec 3, 2025net income per diluted shareFY2026$2.24 – $2.33Raised
Dec 3, 2025net incomeFY2026$197.00M – $205.00MRaised
Dec 3, 2025non-GAAP net incomeFY2026$341.00M – $348.00MRaised
Dec 3, 2025revenuesFY2026$1.30B – $1.31BRaised
Sep 2, 2025Adjusted EBITDAFY2026$540.00M – $560.00MRaised
Sep 2, 2025non-GAAP net income per diluted shareFY2026$3.74 – $3.91Raised

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases HealthEquity filed with the SEC as exhibits to Form 8-K or 6-K

  1. HealthEquity Appoints Moody’s CFO Noémie Heuland
    Update
  2. HealthEquity Reports Second Quarter Ended July 31, 2026 Financial Results
    Results
  3. HealthEquity Reports First Quarter Ended April 30, 2026 Financial Results
    Results
  4. HealthEquity Appoints Sanford Health CEO Bill Gassen
    Update
  5. HealthEquity Reports Record Revenue, Earnings and New HSAs From Sales for Fourth Quarter and Year Ended January 31, 2026, Resulting in Raised Fiscal 2027 Outlook
    Results
  6. HealthEquity Delivers Record Q4 and Standout Fiscal 2026 Sales Metrics
    Results
  7. HealthEquity Announces Fiscal Year 2027 Outlook
    Update
  8. HealthEquity Reports Third Quarter Ended October 31, 2025 Financial Results
    Results
  9. HealthEquity Reports Second Quarter Ended July 31, 2025 Financial Results
    Results
  10. HealthEquity Reports First Quarter Ended April 30, 2025 Financial Results
    Results
  11. HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2025 Financial Results
    Results
  12. HealthEquity Reports Year-End Sales Metrics
    Results
  13. HealthEquity Announces Record Year-End HSA Sales Outlook
    Update
  14. HealthEquity Reports Third Quarter Ended October 31, 2024 Financial Results
    Results
  15. HealthEquity Announces Retirement of CEO Jon Kessler;
    Update